Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
HHS cancels mRNA vaccine development funded by BARDA
The decision affects 22 projects valued at around $500 million collectively, and no new mRNA projects will be started.
Darren Incorvaia
Aug 5, 2025 7:20pm
Pfizer's embattled obesity program loses another GLP-1 drug
Aug 5, 2025 8:51am
BioNTech cuts 90 more US jobs as part of pipeline realignment
Aug 5, 2025 1:24pm
Orchestra BioMed scores $111M, backed by Medtronic, Ligand
Aug 5, 2025 3:41pm
Alcon sees Staar Surgical for $1.5B deal
Aug 5, 2025 11:00am
HMNC recalibrates precision depression push after phase 2b miss
Aug 5, 2025 10:38am
More News
Imunon puts COVID vaccine on ice, seeks partner amid cash crunch
Aug 5, 2025 9:55am
BioMarin drops PKU drug once seen as possible Palynziq successor
Aug 5, 2025 4:48am
Vertex drops asset in acute pain after phase 2 fail
Aug 4, 2025 5:34pm
FDA formally kicks off medical device user fee negotiations
Aug 4, 2025 4:45pm